Get startedLog in
    Picture of ExpreS2ion Biotech Holding AB logo

    EXPRS2 — ExpreS2ion Biotech Holding AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Expres2ion's Associated Company Leads Consortium Awarded USD 12.4 Mln

    Picture of ExpreS2ion Biotech Holding AB logoExpreS2ion Biotech Holding AB
    19/06/2025 09:20
    June 19 (Reuters) - ExpreS2ion Biotech Holding AB EXPRS2.ST:

EXPRES2ION'S ASSOCIATED COMPANY ADAPTVAC TO LEAD CEPI AND EU FUNDED USD 12.4 MILLION CONSORTIUM TO DEVELOP NOVEL FILOVIRUS VACCINE

PROJECT FUNDED OVER FIVE YEARS WITH PLANNED PHASE I/II TRIALS

Source text: ID:nWkr4hlg0x

Further company coverage: EXPRS2.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on ExpreS2ion Biotech Holding AB

    See all news